$500.00
FOXO4-DRI is an anti-aging peptide that targets senescent cells by disrupting the interaction between FOXO4 and the p53 protein. This interference triggers programmed cell death specifically in senescent cells, helping to improve the surrounding tissue environment and slow age-related decline. Through its ability to modulate key signaling pathways and remove dysfunctional cells, FOXO4-DRI has shown potential in areas such as healthy aging research, testicular function studies, radiation-related lung injury models, neurodegenerative conditions, and cardiovascular health investigations. By clearing senescent cells and restoring more normal tissue activity, it offers a promising research direction for understanding and addressing various age-associated biological changes.
The peptide is supplied as a lyophilized powder to maintain optimal stability during storage.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption
